| Cambridge Respiratory Innovations Limited (CRiL) of Swavesey, Cambridgeshire, has been awarded an SBRI Healthcare feasibility study development contract for a self-care asthma monitor using its innovative N-Tidal technology. CRiL has developed an epitaxially-grown LED-based CO2 sensor specifically to measure CO2 in respired breathing. The sensor and technology platform has been proven in COPD and this feasibility study will investigate its potential use in the reversible condition of asthma. The intention is to reduce the demands on primary care through improved management of asthma. 5.4 million people in the UK suffer from asthma, which is generally poorly diagnosed and controlled. |
Comments are closed.